22-50525807-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001953.5(TYMP):​c.1412C>T​(p.Ser471Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0995 in 1,610,390 control chromosomes in the GnomAD database, including 9,556 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S471S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.090 ( 778 hom., cov: 35)
Exomes 𝑓: 0.10 ( 8778 hom. )

Consequence

TYMP
NM_001953.5 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 1.14

Publications

52 publications found
Variant links:
Genes affected
TYMP (HGNC:3148): (thymidine phosphorylase) This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012]
SCO2 (HGNC:10604): (synthesis of cytochrome C oxidase 2) Cytochrome c oxidase (COX) catalyzes the transfer of electrons from cytochrome c to molecular oxygen, which helps to maintain the proton gradient across the inner mitochondrial membrane that is necessary for aerobic ATP production. Human COX is a multimeric protein complex that requires several assembly factors; this gene encodes one of the COX assembly factors. The encoded protein is a metallochaperone that is involved in the biogenesis of cytochrome c oxidase subunit II. Mutations in this gene are associated with fatal infantile encephalocardiomyopathy and myopia 6. [provided by RefSeq, Oct 2014]
SCO2 Gene-Disease associations (from GenCC):
  • cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • myopia 6
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021177828).
BP6
Variant 22-50525807-G-A is Benign according to our data. Variant chr22-50525807-G-A is described in ClinVar as Benign. ClinVar VariationId is 130693.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.241 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYMPNM_001953.5 linkc.1412C>T p.Ser471Leu missense_variant Exon 10 of 10 ENST00000252029.8 NP_001944.1 P19971-1E5KRG5
SCO2NM_005138.3 linkc.-349C>T upstream_gene_variant ENST00000395693.8 NP_005129.2 O43819

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYMPENST00000252029.8 linkc.1412C>T p.Ser471Leu missense_variant Exon 10 of 10 1 NM_001953.5 ENSP00000252029.3 P19971-1
SCO2ENST00000395693.8 linkc.-349C>T upstream_gene_variant 1 NM_005138.3 ENSP00000379046.4 O43819

Frequencies

GnomAD3 genomes
AF:
0.0899
AC:
13689
AN:
152208
Hom.:
778
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0507
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.0697
Gnomad EAS
AF:
0.253
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.0908
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0866
Gnomad OTH
AF:
0.0969
GnomAD2 exomes
AF:
0.128
AC:
29384
AN:
230034
AF XY:
0.125
show subpopulations
Gnomad AFR exome
AF:
0.0493
Gnomad AMR exome
AF:
0.207
Gnomad ASJ exome
AF:
0.0688
Gnomad EAS exome
AF:
0.258
Gnomad FIN exome
AF:
0.0933
Gnomad NFE exome
AF:
0.0885
Gnomad OTH exome
AF:
0.103
GnomAD4 exome
AF:
0.100
AC:
146515
AN:
1458068
Hom.:
8778
Cov.:
39
AF XY:
0.102
AC XY:
74188
AN XY:
725332
show subpopulations
African (AFR)
AF:
0.0482
AC:
1609
AN:
33392
American (AMR)
AF:
0.195
AC:
8676
AN:
44494
Ashkenazi Jewish (ASJ)
AF:
0.0685
AC:
1785
AN:
26060
East Asian (EAS)
AF:
0.240
AC:
9502
AN:
39612
South Asian (SAS)
AF:
0.172
AC:
14851
AN:
86168
European-Finnish (FIN)
AF:
0.0947
AC:
4889
AN:
51608
Middle Eastern (MID)
AF:
0.0638
AC:
365
AN:
5722
European-Non Finnish (NFE)
AF:
0.0885
AC:
98278
AN:
1110890
Other (OTH)
AF:
0.109
AC:
6560
AN:
60122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
7959
15918
23877
31836
39795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3834
7668
11502
15336
19170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0899
AC:
13695
AN:
152322
Hom.:
778
Cov.:
35
AF XY:
0.0928
AC XY:
6912
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0506
AC:
2103
AN:
41586
American (AMR)
AF:
0.133
AC:
2037
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0697
AC:
242
AN:
3470
East Asian (EAS)
AF:
0.253
AC:
1310
AN:
5186
South Asian (SAS)
AF:
0.191
AC:
925
AN:
4832
European-Finnish (FIN)
AF:
0.0908
AC:
964
AN:
10618
Middle Eastern (MID)
AF:
0.0171
AC:
5
AN:
292
European-Non Finnish (NFE)
AF:
0.0866
AC:
5889
AN:
68004
Other (OTH)
AF:
0.0969
AC:
205
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
674
1349
2023
2698
3372
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0890
Hom.:
849
Bravo
AF:
0.0900
TwinsUK
AF:
0.0823
AC:
305
ALSPAC
AF:
0.0924
AC:
356
ESP6500AA
AF:
0.0440
AC:
183
ESP6500EA
AF:
0.0807
AC:
663
ExAC
AF:
0.120
AC:
14146
Asia WGS
AF:
0.229
AC:
793
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Jul 10, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 23, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Mitochondrial DNA depletion syndrome 1 Benign:3
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 14, 2016
GeneReviews
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Spinal muscular atrophy Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Fatal Infantile Cardioencephalomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.20
T;.;T;T;T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.72
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.67
.;T;.;T;T
MetaRNN
Benign
0.0021
T;T;T;T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
1.7
L;.;L;L;.
PhyloP100
1.1
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-0.61
N;N;N;N;N
REVEL
Uncertain
0.32
Sift
Benign
0.40
T;T;T;T;T
Sift4G
Benign
0.33
T;T;T;T;T
Polyphen
0.99
D;.;D;D;.
Vest4
0.28
MPC
0.92
ClinPred
0.033
T
GERP RS
2.2
PromoterAI
0.049
Neutral
Varity_R
0.14
gMVP
0.56
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11479; hg19: chr22-50964236; COSMIC: COSV52688025; COSMIC: COSV52688025; API